Understanding what a product actually contains is essential before making decisions about any concentrated botanical extract. Mitragynine is one of the principal alkaloids found in kratom (Mitragyna speciosa), while 7-hydroxymitragynine, commonly called 7-OH, is another kratom-related compound with substantially different potency and safety considerations. The FDA has specifically warned about concentrated 7-OH products and continues to raise concerns about kratom products.

What Is Mitragynine?

Mitragynine is a naturally occurring alkaloid found in kratom leaves. Kratom is a tropical tree native to Southeast Asia, and its leaves contain numerous alkaloids, including mitragynine and 7-hydroxymitragynine.

The term "extract" generally indicates that compounds have been concentrated from the original plant material. That means an extract tablet should not automatically be viewed as equivalent to ordinary dried kratom leaf.

Several factors can influence what a concentrated product actually delivers:

• The amount of extract used
• The measured concentration of mitragynine
• The presence of other alkaloids
• Whether 7-OH is present or added
• Manufacturing and extraction methods
• Independent laboratory testing
• Product labeling accuracy

For this reason, a percentage printed on a product label should be understood in the context of the complete ingredient profile rather than treated as a simple measure of quality.

What Does "80%" Mean?

The phrase 80% mitragynine extract tablets can be misleading without additional information.

An "80%" claim may refer to a manufacturer's stated extract concentration, but consumers need to know exactly what the percentage represents. It could potentially refer to an extract specification, an alkaloid concentration, or another measurement used by the manufacturer.

Check the Full Product Information

Before considering any concentrated botanical tablet, look for:

• Exact ingredient quantities
• A clearly stated serving size
• Batch or lot information
• Independent laboratory testing
• Testing for contaminants
• Testing for unwanted or undeclared alkaloids
• Manufacturer contact information
• Clear labeling without exaggerated health claims

Laboratory testing can be particularly important because the FDA has reported finding significant levels of lead and nickel in some kratom products it tested.

Mitragynine vs. 7-Hydroxymitragynine

One of the most important distinctions is between mitragynine and 7-OH.

Although both are associated with kratom, they are not interchangeable. The FDA describes 7-OH as a more potent opioid-related compound than mitragynine and has raised particular concerns about products containing enhanced or concentrated levels of 7-OH.

This distinction matters because some products use terminology that can make different alkaloid products appear similar.

Why the Label Matters

A product marketed around mitragynine should not automatically be assumed to contain a particular amount of 7-OH. Conversely, a product advertised as a highly concentrated kratom or 7-OH product deserves additional scrutiny.

The FDA states that products containing concentrated 7-OH have not been proven safe or effective for any use and recommends that consumers avoid them.

Safety Considerations for Concentrated Extracts

Concentrated botanical extracts can create different safety considerations from traditional plant material. Higher concentrations may make accurate labeling and quality control especially important.

The FDA has reported safety concerns associated with kratom products, including liver toxicity, seizures, gastrointestinal problems, cardiovascular effects, respiratory depression, addiction, withdrawal symptoms, and other serious adverse events.

This does not mean every product has identical risks, but it does demonstrate why consumers should avoid assuming that "plant-based" automatically means safe.

People who take prescription medications, have underlying medical conditions, are pregnant or breastfeeding, or are concerned about substance interactions should speak with a qualified healthcare professional before using concentrated botanical products.

How to Evaluate an Extract Tablet

If you're researching products described as 80% mitragynine extract tablets, take a closer look at the information behind the marketing language.

Look for Transparent Testing

A reputable product should provide meaningful information about what was tested and what the results showed. A certificate of analysis, when available, can help consumers understand whether an independent laboratory evaluated the product.

Examine the Ingredient List

Do not focus on one headline number alone. Check whether the product lists:

• Mitragynine
• 7-OH or 7-hydroxymitragynine
• Other alkaloids
• Fillers or excipients
• Botanical ingredients
• Potential allergens

Be Cautious With Medical Claims

Claims that a kratom extract can treat pain, anxiety, opioid withdrawal, depression, or other medical conditions require particular caution. The FDA has repeatedly taken action against products marketed with unapproved therapeutic claims.

Why Concentration and Quality Shouldn't Be Confused

A higher percentage does not automatically mean a product is better. Concentration describes a chemical characteristic, while quality involves many additional factors.

A quality-focused evaluation may consider:

• Accurate labeling
• Consistent manufacturing
• Independent testing
• Contaminant screening
• Ingredient transparency
• Appropriate packaging
• Responsible marketing

This approach is more useful than judging a botanical product solely by the largest percentage displayed on its packaging.

A Smarter Approach to Functional Products

Consumers interested in botanical beverages, functional ingredients, or wellness-oriented products increasingly have many formats to consider. Powders, drinks, capsules, tablets, and ready-to-consume products can all have different ingredient profiles and usage considerations.

When exploring a new product category, start with the ingredient list and available testing rather than relying entirely on promotional language.

For people exploring functional beverage options, Drink Jubi can also be part of a broader search for convenient beverage choices, while consumers should always review the specific ingredients and product information before making a purchase.

Final Thoughts

The term 80% mitragynine extract tablets describes a highly concentrated-sounding product category, but the percentage alone does not provide enough information to determine what a product contains or how it should be evaluated.

Mitragynine and 7-OH are different kratom-related alkaloids, and concentrated 7-OH products have received specific FDA warnings because of their potential risks.

If you're researching concentrated botanical products, take time to examine the complete label, laboratory testing, ingredient profile, manufacturer information, and applicable regulations. Avoid assuming that higher concentration means higher quality, and be particularly cautious about products making strong medical or therapeutic promises.

For consumers exploring convenient functional beverage choices alongside other product categories, Drink Jubi encourages a thoughtful approach: read the label, understand the ingredients, and make informed choices based on reliable product information.